|
Diabetes, Vol 49, Issue 3 517-520, Copyright © 2000 by American Diabetes Association
Interleukin-6 gene polymorphism and insulin sensitivity
JM Fernandez-Real, M Broch, J Vendrell, C Gutierrez, R Casamitjana, M Pugeat, C Richart and W Ricart
Unitat de Diabetologia, Endocrinologia i Nutricio, University Hospital of Girona Dr Josep Trueta, Spain. endocrino@htrueta.scs.es
Type 2 diabetes and the insulin resistance syndrome have been hypothesized
to constitute manifestations of an ongoing acute-phase response. We aimed
to study an interleukin-6 (IL-6) gene polymorphism in relation to insulin
sensitivity (IL-6 is the main cytokine involved in an acute-phase
response). Subjects homozygous for the C allele at position -174 of the
IL-6 gene (SfaNI genotype), associated to lower plasma IL-6 levels, showed
significantly lower integrated area under the curve of serum glucose
concentrations (AUCglucose) after an oral glucose tolerance test, lower
blood glycosylated hemoglobin, lower fasting insulin levels, lower total
and differential white blood cell count (a putative marker of peripheral
IL-6 action), and an increased insulin sensitivity index than carriers of
the G allele, despite similar age and body composition. A gene dosage
effect was especially remarkable for AUCglucose (6.4 vs. 9.3 vs. 9.7 mmol/l
in C/C, C/G, and G/G individuals, respectively). The serum concentration of
fully glycosylated cortisol binding globulin (another marker of IL-6
action), suggested by concanavalin A adsorption, was lower in C/C subjects
than in G/G individuals (32.6+/-2.9 vs. 37.6+/-4.6 mg/l, P = 0.03). In
summary, a polymorphism of the IL-6 gene influences the relationship among
insulin sensitivity, postload glucose levels, and peripheral white blood
cell count.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Qi, N. Rifai, and F. B. Hu
Interleukin-6 Receptor Gene Variations, Plasma Interleukin-6 Levels, and Type 2 Diabetes in U.S. Women
Diabetes,
December 1, 2007;
56(12):
3075 - 3081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Giannoudis, M. van Griensven, E. Tsiridis, and H. C. Pape
The genetic predisposition to adverse outcome after trauma
J Bone Joint Surg Br,
October 1, 2007;
89-B(10):
1273 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Glund, A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, J. R. Zierath, and A. Krook
Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle
Diabetes,
June 1, 2007;
56(6):
1630 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bamoulid, C. Courivaud, M. Deschamps, P. Mercier, C. Ferrand, A. Penfornis, P. Tiberghien, J.-M. Chalopin, P. Saas, and D. Ducloux
IL-6 Promoter Polymorphism -174 Is Associated with New-Onset Diabetes after Transplantation
J. Am. Soc. Nephrol.,
August 1, 2006;
17(8):
2333 - 2340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Qi, R. M. van Dam, J. B. Meigs, J. E. Manson, D. Hunter, and F. B. Hu
Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis
Hum. Mol. Genet.,
June 1, 2006;
15(11):
1914 - 1920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Oberbach, A. Tonjes, N. Kloting, M. Fasshauer, J. Kratzsch, M. W Busse, R. Paschke, M. Stumvoll, and M. Bluher
Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.
Eur. J. Endocrinol.,
April 1, 2006;
154(4):
577 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. P. Kristiansen and T. Mandrup-Poulsen
Interleukin-6 and Diabetes: The Good, the Bad, or the Indifferent?
Diabetes,
December 1, 2005;
54(suppl_2):
S114 - S124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cardellini, L. Perego, M. D'Adamo, M. A. Marini, C. Procopio, M. L. Hribal, F. Andreozzi, S. Frontoni, M. Giacomelli, M. Paganelli, et al.
C-174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin Resistance
Diabetes Care,
August 1, 2005;
28(8):
2007 - 2012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Endocr. Rev.,
April 1, 2005;
26(2):
251 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R. E. Hendler, and G. I. Shulman
Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes
Diabetes,
March 1, 2005;
54(3):
603 - 608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Roberts, H.-C. Pape, A. L. Jones, A. L. Malkani, J. L. Rodriguez, and P. V. Giannoudis
Damage Control Orthopaedics. Evolving Concepts in the Treatment of Patients Who Have Sustained Orthopaedic Trauma
J. Bone Joint Surg. Am.,
February 1, 2005;
87(2):
434 - 449.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, Z. Zhang, W. Chu, T. Hale, J. J. Cooper, and S. C. Elbein
Molecular Screening and Association Analyses of the Interleukin 6 Receptor Gene Variants with Type 2 Diabetes, Diabetic Nephropathy, and Insulin Sensitivity
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
1123 - 1129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Staiger, K. Staiger, N. Stefan, H. G. Wahl, F. Machicao, M. Kellerer, and H.-U. Haring
Palmitate-Induced Interleukin-6 Expression in Human Coronary Artery Endothelial Cells
Diabetes,
December 1, 2004;
53(12):
3209 - 3216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lappas, M. Permezel, and G. E. Rice
Release of Proinflammatory Cytokines and 8-Isoprostane from Placenta, Adipose Tissue, and Skeletal Muscle from Normal Pregnant Women and Women with Gestational Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
November 1, 2004;
89(11):
5627 - 5633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Illig, F. Bongardt, A. Schopfer, S. Muller-Scholze, W. Rathmann, W. Koenig, B. Thorand, C. Vollmert, R. Holle, H. Kolb, et al.
Significant Association of the Interleukin-6 Gene Polymorphisms C-174G and A-598G with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
5053 - 5058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. McKenzie, E. P. Weiss, I. A. Ghiu, O. Kulaputana, D. A. Phares, R. E. Ferrell, and J. M. Hagberg
Influence of the interleukin-6 -174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indexes
J Appl Physiol,
October 1, 2004;
97(4):
1338 - 1342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Di Gregorio, L. Hensley, T. Lu, G. Ranganathan, and P. A. Kern
Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity
Am J Physiol Endocrinol Metab,
July 1, 2004;
287(1):
E182 - E187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ueki, T. Kondo, and C. R. Kahn
Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms
Mol. Cell. Biol.,
June 15, 2004;
24(12):
5434 - 5446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian, T. Pischon, S. E Hankinson, N. Rifai, K. Joshipura, W. C Willett, and E. B Rimm
Dietary intake of trans fatty acids and systemic inflammation in women
Am. J. Clinical Nutrition,
April 1, 2004;
79(4):
606 - 612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mohlig, H. Boeing, J. Spranger, M. Osterhoff, A. Kroke, E. Fisher, M. M. Bergmann, M. Ristow, K. Hoffmann, and A. F. H. Pfeiffer
Body Mass Index and C-174G Interleukin-6 Promoter Polymorphism Interact in Predicting Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
April 1, 2004;
89(4):
1885 - 1890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Kim, T. Higashimori, S.-Y. Park, H. Choi, J. Dong, Y.-J. Kim, H.-L. Noh, Y.-R. Cho, G. Cline, Y.-B. Kim, et al.
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Diabetes,
April 1, 2004;
53(4):
1060 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Pickup
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Diabetes Care,
March 1, 2004;
27(3):
813 - 823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wolf, J. Sauk, A. Shah, K. Vossen Smirnakis, R. Jimenez-Kimble, J. L. Ecker, and R. Thadhani
Inflammation and Glucose Intolerance: A prospective study of gestational diabetes mellitus
Diabetes Care,
January 1, 2004;
27(1):
21 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Roth, M. A. Schrager, M. R. Lee, E. J. Metter, B. F. Hurley, and R. E. Ferrell
Interleukin-6 (IL6) Genotype Is Associated With Fat-Free Mass in Men But Not Women
J. Gerontol. A Biol. Sci. Med. Sci.,
December 1, 2003;
58(12):
B1085 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kubaszek, J. Pihlajamaki, V. Komarovski, V. Lindi, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, et al.
Promoter Polymorphisms of the TNF-{alpha} (G-308A) and IL-6 (C-174G) Genes Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The Finnish Diabetes Prevention Study
Diabetes,
July 1, 2003;
52(7):
1872 - 1876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev.,
June 1, 2003;
24(3):
278 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Belluco, F. Olivieri, M. Bonafe, S. Giovagnetti, E. Mammano, R. Scalerta, A. Ambrosi, C. Franceschi, D. Nitti, and M. Lise
-174G>C Polymorphism of Interleukin 6 Gene Promoter Affects Interleukin 6 Serum Level in Patients with Colorectal Cancer
Clin. Cancer Res.,
June 1, 2003;
9(6):
2173 - 2176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Fernandez-Real, M. Broch, C. Richart, J. Vendrell, A. Lopez-Bermejo, and W. Ricart
CD14 Monocyte Receptor, Involved in the Inflammatory Cascade, and Insulin Sensitivity
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1780 - 1784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kubaszek, J. Pihlajamaki, K. Punnonen, P. Karhapaa, I. Vauhkonen, and M. Laakso
The C-174G Promoter Polymorphism of the IL-6 Gene Affects Energy Expenditure and Insulin Sensitivity
Diabetes,
February 1, 2003;
52(2):
558 - 561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wieser, G. Fabjani, C. Tempfer, C. Schneeberger, M. Sator, J. Huber, and R. Wenzl
Analysis of an Interleukin-6 Gene Promoter Polymorphism in Women With Endometriosis Polymorphism in Women With Endometriosis By Pyrosequencing
Reproductive Sciences,
January 1, 2003;
10(1):
32 - 36.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney
Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes
Diabetes,
December 1, 2002;
51(12):
3391 - 3399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Jenny, R. P. Tracy, M. S. Ogg, L. A. Luong, L. H. Kuller, A. M. Arnold, A. R. Sharrett, and S. E. Humphries
In the Elderly, Interleukin-6 Plasma Levels and the -174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2002;
22(12):
2066 - 2071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, and D. Giugliano
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Circulation,
October 15, 2002;
106(16):
2067 - 2072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Fernandez-Real, M. Pugeat, M. Grasa, M. Broch, J. Vendrell, J. Brun, and W. Ricart
Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study
J. Clin. Endocrinol. Metab.,
October 1, 2002;
87(10):
4686 - 4690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. FEBBRAIO and B. K. PEDERSEN
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles
FASEB J,
September 1, 2002;
16(11):
1335 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, W. S. Chu, C. Hemphill, and S. C. Elbein
Human Resistin Gene: Molecular Scanning and Evaluation of Association with Insulin Sensitivity and Type 2 Diabetes in Caucasians
J. Clin. Endocrinol. Metab.,
June 1, 2002;
87(6):
2520 - 2524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Villuendas, J. L. San Millan, J. Sancho, and H. F. Escobar-Morreale
The -597 G->A and -174 G->C Polymorphisms in the Promoter of the IL-6 Gene Are Associated with Hyperandrogenism
J. Clin. Endocrinol. Metab.,
March 1, 2002;
87(3):
1134 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Vozarova, C. Weyer, R. S. Lindsay, R. E. Pratley, C. Bogardus, and P. A. Tataranni
High White Blood Cell Count Is Associated With a Worsening of Insulin Sensitivity and Predicts the Development of Type 2 Diabetes
Diabetes,
February 1, 2002;
51(2):
455 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Fernandez-Real, M. Vayreda, C. Richart, C. Gutierrez, M. Broch, J. Vendrell, and W. Ricart
Circulating Interleukin 6 Levels, Blood Pressure, and Insulin Sensitivity in Apparently Healthy Men and Women
J. Clin. Endocrinol. Metab.,
March 1, 2001;
86(3):
1154 - 1159.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|